Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

741
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
741
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

601
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
601
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

164
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
164
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

355
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
355
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

198
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
198
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

614
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
614

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and Rationale of the REVEAL PET Study: A Study of <sup>124</sup>I-evuzamitide to Diagnose Cardiac Amyloidosis.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2026
Same author

Thiazides Attenuate the Diuretic Response to Pecavaptan, a Dual Vasopressin Receptor Antagonist, in Patients Hospitalized for Heart Failure.

Journal of cardiac failure·2026
Same author

Vagal Nerve Stimulation in Patients With Heart Failure and Reduced Ejection Fraction: The ANTHEM-HFrEF Trial.

Journal of the American College of Cardiology·2026
Same author

Improved assessment of coronary artery disease in obese Patients with flurpiridaz-<sup>18</sup>F positron emission tomography myocardial perfusion imaging: A prespecified subgroup analysis of the AURORA phase 3 study.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2026
Same author

Fluid Management of Acute Heart Failure With the Reprieve System: The Randomized Controlled FASTR Trial.

JACC. Heart failure·2026
Same author

Cardiac Fibrosis-An Emerging Diagnostic and Therapeutic Target.

JAMA cardiology·2026

Related Experiment Video

Updated: Dec 27, 2025

Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
10:21

Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test

Published on: September 22, 2023

905

Hypervolemic Hyponatremia in Heart Failure.

Carlos D Davila, James E Udelson

    Frontiers of Hormone Research
    |February 26, 2020
    PubMed
    Summary
    This summary is machine-generated.

    Heart failure (HF) commonly causes hypervolemic hyponatremia, linked to poorer patient outcomes. This summary covers HF hyponatremia

    More Related Videos

    Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
    07:49

    Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

    Published on: July 21, 2023

    1.8K
    Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
    07:59

    Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

    Published on: July 28, 2018

    11.6K

    Related Experiment Videos

    Last Updated: Dec 27, 2025

    Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
    10:21

    Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test

    Published on: September 22, 2023

    905
    Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
    07:49

    Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

    Published on: July 21, 2023

    1.8K
    Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
    07:59

    Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

    Published on: July 28, 2018

    11.6K

    Area of Science:

    • Cardiology
    • Nephrology
    • Endocrinology

    Background:

    • Heart failure (HF) is the primary cause of hypervolemic hyponatremia.
    • Hyponatremia in HF patients is associated with adverse clinical outcomes.
    • Complex neurohormonal and cardio-renal interactions contribute to HF-related hyponatremia.

    Purpose of the Study:

    • To review the pathophysiology of hyponatremia in heart failure.
    • To summarize current evidence and management strategies for hyponatremia in HF.
    • To focus on arginine vasopressin (AVP) homeostasis in this context.

    Main Methods:

    • Literature review of pathophysiology, clinical evidence, and treatment guidelines.
    • Analysis of neurohormonal and cardio-renal mechanisms.
    • Focus on arginine vasopressin (AVP) system's role.

    Main Results:

    • Hyponatremia in HF results from increased arginine vasopressin (AVP) secretion and impaired renal diluting capacity.
    • Treatment strategies include decongestant therapy, diuretics, neurohormonal blockade, and AVP antagonists.
    • AVP homeostasis is a critical factor in HF hyponatremia management.

    Conclusions:

    • Understanding AVP's role is key to managing hyponatremia in heart failure.
    • Integrated therapeutic approaches are necessary for optimal patient outcomes.
    • Further research into AVP modulation may offer novel treatment avenues.